Cargando…
Molecular Engineering of Peptide–Drug Conjugates for Therapeutics
In recent years, hundreds of novel small molecular drugs used for different treatments have been studied in the three phases of clinical trials around the world. However, less than 10% of them are eventually used due to diverse problems. Even some traditional drugs that have been approved by the Foo...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779610/ https://www.ncbi.nlm.nih.gov/pubmed/35057106 http://dx.doi.org/10.3390/pharmaceutics14010212 |